Global Latent Tuberculosis Infection (LTBI) Testing Market: Size and Trends with Impact of COVID-19 and Forecast up to 2027

The global latent tuberculosis infection (LTBI) testing market in 2021 was valued at US$1.75 billion. The market value is expected to reach US$2.47 billion by 2027. Latent Tuberculosis tests diagnose latent tuberculosis which is the type of TB infection where the bacteria remains inactive i.e., bacteria are present in the sleeping state inside the body. This infection can only be manifested through the tuberculin skin test (TST). In spite of this, there is a continuing risk that the latent infection may step up to active TB disease. The risk is increased by other illnesses such as HIV, drug abuse or medications which weakens the immune system.

The market is expected to grow at a CAGR of 5.95% during the forecast period of 2022-2027. Due to the aging population, upsurge in cigarette consumption and growth in pharmaceutical research and development, the market would propel in the forthcoming years. The global LTBI testing market volume reached 83.84 million in 2021.

 

Scope of the Report:

The report titled “Global Latent Tuberculosis Infection (LTBI) Testing Market: Analysis By Type (Tuberculin Skin Test LTBI Testing and Interferon Gamma Released Assay (IGRA) LTBI Testing), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2027”, includes :

-- An in-depth analysis of the global latent tuberculosis infection (LTBI) testing market by value, by volume, by type, by region, etc.

-- The regional analysis of the LTBI testing market, including the following regions:

North America (The US, Canada, and Mexico)
Europe (Germany, The UK, France, Italy, Spain, and Rest of the Europe)
Asia Pacific (China, Japan and Rest of Asia Pacific)
Middle East & Africa
Latin America

-- Comprehensive information about emerging markets. This report analyses the market for various segments across geographies.

-- Provides an analysis of the COVID-19 impact on the global LTBI testing market.

-- Assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall the LTBI testing market has also been forecasted for the period 2022-2027, taking into consideration the previous growth patterns, the growth drivers, and the current and future trends.

-- Evaluation of the potential role of the LTBI testing to improve the market status.

-- Identification of new technological developments, R&D activities, and product launches occuring in the LTBI testing market.

-- In-depth profiling of the key players, including the assessment of the business overview, market strategies, regional and business segments of the leading players in the market.

-- The recent developments, mergers and acquisitions related to mentioned key players are provided in the market report.

-- The in-depth analysis provides an insight into the market, underlining the growth rate and opportunities offered in the business.

 

 

 

For further details, kindly visit :

https://www.daedal-research.com/pharma-healthcare/global-latent-tuberculosis-infection-ltbi-testing-market-size-and-trends-with-impact-of-covid-19-and-forecast-up-to-2027

 

Rajeev Kumar

(Business Development Manager)

Address:  36 SFS Flats

Paschim Vihar

New Delhi-110063

Mobile: +91-9811715635

Tel: +91-120-4553017

Mail ID - info@daedal-research.com

 

Content Source - Daedal Research

Enquiry For